Collectively, our results demonstrated that LINC01133 was frequently amplified at the genomic‐sequence level and overexpressed at the transcript level in the tumors of patients that experienced HCC, implying that LINC01133 plays a role in HCC recurrence and prognosis. This evidence concerns the gene LINC01133 and hepatocellular carcinoma.